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Structural heterogeneity of the 
μ-opioid receptor’s conformational 
ensemble in the apo state
Diniz M. Sena Jr1,2,3,*, Xiaojing Cong1,2,*, Alejandro Giorgetti2,4, Achim Kless5 & Paolo Carloni1,2
G-protein coupled receptors (GPCRs) are the largest and most pharmaceutically relevant family of 
membrane proteins. Here, fully unbiased, enhanced sampling simulations of a constitutively active 
mutant (CAM) of a class A GPCR, the μ-opioid receptor (μOR), demonstrates repeated transitions 
between the inactive (IS) and active-like (AS-L) states. The interconversion features typical activation/
inactivation patterns involving established conformational rearrangements of conserved residues. 
By contrast, wild-type μOR remains in IS during the same course of simulation, consistent with the 
low basal activity of the protein. The simulations point to an important role of residue W2936.48 at the 
“toggle switch” in the mutation-induced constitutive activation. Such role has been already observed 
for other CAMs of class A GPCRs. We also find a significantly populated intermediate state, rather similar 
to IS. Based on the remarkable accord between simulations and experiments, we suggest here that this 
state, which has escaped so far experimental characterization, might constitute an early step in the 
activation process of the apo μOR CAM.
G-protein coupled receptors (GPCRs) are the largest protein family of transmembrane receptors in eukaryotes 
with ~800 members in the human genome1. They are responsible for ~80% of cell trafficking2, constituting the tar-
gets of almost half of FDA-approved drugs3. Agonist binding (photon absorption in the case of the photoreceptor 
rhodopsin) steers conformational and functional changes, leading to the activation of its cognate G-proteins 
in the cytoplasm. This in turn triggers downstream signaling events4. Most insights into GPCR activation have 
emerged for class A (or rhodopsin-like) receptors4, accounting for ~85% members of the family1: the activation 
involves specific conformational changes in the seven transmembrane helices (TM1–7), especially in highly con-
served motifs (called at times ‘intramolecular switches’, Fig. 1). Namely, the intracellular end of TM6 bends by as 
much as ~10 Å away from the helical core5,6, whereas that of TM7 moves toward the core7. The latter, along with 
the intracellular halves of TMs 2, 3, and 6 rearrange so as to open a ‘hydrophobic barrier’4. This concerts with 
the so-called ‘rotamer toggle switch’ to form a water channel connecting the extra- and intracellular sides8–11. 
Between the toggle switch and the hydrophobic barrier lies the allosteric sodium binding pocket (Fig. 1), which 
collapses upon activation. Indeed, sodium binding may stabilize inactive states (IS) while being incompatible with 
active states (AS)12.
Constitutive activity has been observed for many wild type (WT) and mutated GPCRs in the apo state13,14, 
including the human μ OR15,16. In constitutively active mutants (CAMs), ligand-independent activity of the 
receptor is notably higher than the WT, while agonist-induced activity may or may not be affected16,17. While 
possible roles of known mutations from the sequence/structural aspects have been discussed18,19, molecular sim-
ulations of CAMs have provided valuable insights into GPCRs activation13,14,17,20–22 and on the function of other 
membrane proteins23–25. However, little is known about the impact of CAM on GPCR’s entire conformational 
ensemble. Hence, a comprehensive molecular description of GPCR constitutive activation remains obscure. 
This important issue is investigated here, for the first time, using apo μ OR as a test case. Specifically, we use 
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molecular dynamics simulations to study the activation of the apo μ OR N1503.35 A CAM (superscript refers to 
the Ballesteros-Weinstein numbering26). This is a particularly effective CAM as it is more active than WT μ OR in 
the presence or absence of agonists16. The markedly different activity between the WT and the CAM is believed 
to arise, at least in part, from the disruption of the allosteric Na+ binding site, present across class A GPCRs12. 
Indeed, the ion stabilizes IS, and reducing Na+-binding may facilitate the transition towards activation12.
We performed replica exchange with solute scaling (REST2)27 molecular dynamics (MD) simulations of the 
CAM and of the WT apo μ OR. With this enhanced sampling method, each system underwent 20 ns × 64 replicas 
MD at different temperatures, for a total of 1.28 μ s. The initial structure was based on the X-ray crystal structure of 
μ OR IS covalently bound with an irreversible antagonist, β -funaltrexamine (β -FNA) (PDB ID: 4DKL)28. We chose 
this crystal structure as it shows none of the well-known typical activation traits (Fig. 1)4. Comparison between 
the CAM and WT apo μ OR shows that the CAM converts frequently from IS to AS-like and intermediate states. 
One of the states shares activation features with the AS. By contrast, the WT remains trapped in the IS.
Results
Transitions from GPCR inactive to active states are rare events estimated to take place at millisecond timescale29. 
Hence, here we do not use straightforward MD, which typically covers a much shorter (microsecond) timescale 
than that of the transitions (apart from notable exceptions30,31). The REST227 scheme used here is one of the 
so-called “enhanced sampling methods”. It enhances free energy barrier crossing, allowing sampling of rare events 
with much shorter computational efforts. The 1.28 μ s of REST2 simulations collected here do not correspond 
to actual dynamics but rather to the sum of multiple discontinuous dynamics. Only the replica of the original 
canonical ensemble (the one at room-temperature) is analyzed and presented below. The other high-temperature 
replicas serve solely to enhance the sampling within the REST2 scheme. Thus, the trajectory obtained from the 
REST2 MD does not correspond to a progressive pathway of single conformations, but rather to interconversions 
among ensembles of conformations.
Comparison of the simulated ensemble with X-ray crystal structures of μ OR IS (Xtl-IS) and AS (PDB ID: 
5C1M, “Xtl-AS” hereafter)8 shows that the CAM never reaches the fully active state as that in the available 
agonist- and nanobody-bound Xtl-AS8. Indeed, solution-state NMR has shown that both the agonist and the G 
protein mimetic nanobody are required to stabilize full AS of μ OR10. However, one of the states does share most 
of the known activation features (Fig. 1) with Xtl-AS. We call this state an “active-like” state (AS-L, hereafter). 
During the simulation, the CAM interconverts many times between IS (95% overall population of the predicted 
ensemble) and AS-L (5% population, Fig. 2) states, suggesting the adequate sampling of the states. Hence, our 
simulations lead us to suggest that, in the apo receptor, the fully active state as obtained by agonist and nanobody 
binding in Xtl-AS is absent. The WT remains trapped in IS and compares fairly well with the CAM IS, except for 
minor differences due to the mutation (SI-1).
Cluster analysis of the simulated ensemble (see SI-Methods) shows that the CAM AS-L consists of only one 
cluster. The latter overlaps fairly well with Xtl-AS (Fig. 2, Movie 1). The intracellular end of TM6 in the CAM 
AS-L is displaced outward from the helical bundle (Fig. 2). This is the most characteristic structural feature of 
class A GPCR AS5,6. However, in the absence of G protein the TM6 outward displacement in the CAM AS-L is 
less pronounced as that in Xtl-AS (Fig. S2). A similar feature is reported for active-intermediate-like GPCR crystal 
structures without G protein, including the NTS1 mutants in complex with neurotensin (PDB IDs: 5T0417 and 
4XEE/4XES32) and the adenosine A2A receptor in complex with adenosine (PDB ID: 2YDO33).
The IS↔ AS-L transitions reproduce several of the common structural features (Fig. 1) of agonist-induced 
conformational changes in class A GPCRs (Fig. 3, Movie 2)4: at the rotamer toggle switch (F2896.44/W2936.48/
I1553.40/P2445.50), I1553.40 rotates and locks between W2936.48 and F2896.44 (Fig. 3a and Fig. S3a). TM5 at the 
P2445.50 induced bulge moves toward F2896.44 (Fig. S3b). The hydrophobic barrier below it (residues I1072.43, 
L1102.46, L1583.43, M1613.46, M2816.36, V2826.37 and V2856.40) opens to form a water channel (Fig. 3a and Fig. S4a). 
V2826.37, M1613.46 and Y3367.53 rearrange to release V2826.37 from the core (Fig. 3b and Fig. S4b), which is impor-
tant for G protein activation as recently proposed34. R1653.50 in the highly conserved “DRY motif ”35 extends into 
Figure 1. Class A GPCR structure (left) and activation patterns (right) represented here by μOR X-ray 
structures. 
www.nature.com/scientificreports/
3Scientific RepoRts | 7:45761 | DOI: 10.1038/srep45761
the water channel to the position for binding G protein (Fig. 3a and Fig. S5a), as seen in crystal structures of 
GPCR AS bound to a G protein36. The intracellular half of TM7 comprising the N7.49P7.50x7.51x7.52Y7.53 motif moves 
inward and the allosteric Na+-binding site collapses. Moreover, Y3367.53 moves to the center and reaches Y2525.58 
to extend the hydrogen-bond network from the water channel toward TM5 (Fig. 3b and Fig. S4b). The above fea-
tures take place concurrently (Figs S2–S5 and Fig. 5). However, the TM6 outward displacement is slightly more 
pronounced in part of the CAM AS-L cluster (2% out of the 5% population), as reflected in Figs S2a and S4a.
The rest of the CAM structural ensemble consists instead of five other major microstates (Cα ’s RMSD < 1.5 Å 
with respect to Xtl-IS, Fig. S6), as shown by principal component analysis (PCA)-based clustering. Four of them 
constitute the IS (I-IV, Cα ’s RMSD 1.2 ± 0.1 Å–1.4 ± 0.1 Å with respect to Xtl-IS, Fig. S1a), and the other one is 
likely an intermediate state (INT, Cα ’s RMSD 1.4 ± 0.2 Å).
The INT consists of 28% of the ensemble (Fig. S6). We suggest that this is an intermediate state because it 
exhibits “Xtl-AS-like” features at the orthosteric pocket. In particular, Y1282.64 inserts between TM1 and TM7, 
and the orthosteric pocket shows a general twist, similarly to what happens in Xtl-AS (Fig. S7). However, these 
features are not accompanied by typical GPCR activation traits shown in Fig. 1. We have compared INT with the 
Figure 2. Simulated CAM IS (blue) and AS-L (green) structures superimposed onto the correspondent 
X-ray structures of the WT protein (gray and magenta). Only the TM helices are shown (Cα ’s RMSD 0.9 Å 
and 1.8 Å, respectively). The distance between I2796.34 and T1032.39 Cα atoms (double-headed red arrow) 
increases from ~9 Å (IS) to 15 ± 0.9 Å (AS-L), indicating the dramatic outward displacement of TM6 upon 
activation, typical of Class A GPCRs.
Figure 3. Typical activation features arising from CAM IS to AS-L transitions. (a) The toggle switch (blue) 
rotation concerts with the opening of the hydrophobic barrier (yellow dots) and formation of the water channel 
upon activation. Water molecules inside the channel are shown in red spheres. Blue dashed lines indicate 
hydrogen bonds. (b) Rearrangements of V2826.37, M1613.46 and Y3367.53 upon activation: Y3367.53 interacts with 
M1613.46 and V2826.37 is released. This latter interaction is monitored here by the minimal sidechain distance 
between M1613.46 and V2826.37 (Fig. S4b).
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above-mentioned active-intermediate-like states of GPCRs X-ray structures17,32,33. INT does not show features 
typical of these active states. Rather, it shows unique features that are not seen in experimentally characterized 
microstates so far. Specifically, residues Y1282.64, Y1483.33, F1523.37, F1563.41, I1984.56 and Y2525.58 reorient simul-
taneously (Fig. 4), and the orthosteric binding site shape changes (Fig. S8). In particular, Y2525.58 moves to an 
opposite direction to that in AS-L, as can be observed by measuring its distance to Y3367.53 (Fig. 4 and Fig. S5b). 
We conclude that INT is an intermediate state not yet observed in GPCR structures.
Discussion
The four CAM IS states comprise about two thirds of the whole ensemble (populations in Fig. S6). They are quite 
similar to the Xtl-IS, slightly differing only, as expected, at the mutation and the orthosteric site. In particular, 
TM6 is located exactly as in the Xtl-IS (Fig. 2) and the typical GPCR’s activation traits (Fig. 1) are absent.
The interconversion between inactive and active states observed for the CAM, but not for the WT, are consist-
ent with the relatively high and low basal activities of apo N1503.35A μ OR and apo WT μ OR, respectively16. The 
CAM AS-L differs from the Xtl-AS mainly in the orientation of Q1242.60, Y1282.64 and W2936.48 at the orthosteric 
site and in the position of TM6 and TM7 (Fig. S9). These are likely due to the absence of the co-crystallized ligand 
and the nanobody in Xtl-AS8, respectively. Despite the relatively large RMSD from the Xtl-AS, CAM AS-L repro-
duces mostly the well-known structural features of GPCR active state (Figs S2–S5 and Table S1). Hence, CAM 
features a transition from IS to a partially active state. By contrast, the WT shows none of these features under 
the same enhanced-sampling simulation conditions. Therefore, it is clearly the presence of the mutation that pro-
motes the transition to AS. This finding must be considered as a true prediction, as our simulations do not have 
any prior information either on AS or on other intermediate microstates between IS and AS.
Figure 5. Sidechain dihedral angle χ2 of W2936.48 in the CAM (red lines) and the WT (black lines) 
trajectories. Left panels plot the measures in the CAM (red lines) and the WT (black lines) trajectories. Right 
panels show the probability density of the dihedrals, in which dashed vertical lines indicate the corresponding 
values in Xtl-AS (magenta), Xtl-IS (black) and CAM AS-L (mean value of the cluster, green).
Figure 4. The predicted INT structure from enhanced sampling simulations of apo N1503.35A μOR. Here, 
the side chains of Y1283.33, Y1483.33, F1523.37, F1563.41, I1984.56 and Y2525.58 display concerted reorientation when 
compared with Xtl-IS (right). In the WT ensemble, only F1523.37 and I1984.56 reorient in one out of four clusters 
(26% population). For clarity, the extracellular half of TM6 is not shown.
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To examine whether the WT and the CAM show similar conformational changes, we analyzed the dot product 
of the first 9 principal components. These account for more than 65% of the variance (Fig. S12 a and b). It turns 
out that the CAM and the WT show rather different principal components (Table S3). This is not unexpected as 
the CAM undergoes transitions to the intermediate state and the active-like state, whereas the WT mainly fluctu-
ates near the initial inactive state (Figs S14 and S15).
Which structural aspects of the CAM contribute to facilitating the transitions to AS? In an effort at addressing 
this issue, we have compared structural differences between the CAM IS and the WT (Table 1). A direct impact 
of the mutation in the CAM is the elimination of one of the allosteric Na+-binding residues. Consequently, Na+ 
ion binding lifetime (cumulative residence time fraction) at this site is largely reduced in the CAM with respect 
to that in the WT (Table 1). This is consistent with the notion that Na+ ion stabilizes IS. Hence, reducing Na+ 
binding may facilitate activation12.
A second difference is given by the conformation of one residue, W2936.48, in the “toggle switch”, near the 
mutation site. This residue plays a major role in activation by changing its conformation4. Our simulations indi-
cate that this is the case in the CAM and it is not in the WT (Fig. 5 and Table 1). The change of conformation 
of W2936.48 is in line with MD studies on GPCR CAMs other than the one studied here17,20. In particular, these 
studies have shown that W2936.48 orientation differs substantially on passing from CAM to non-CAM mutants 
and the WT17,20. The same is true here. We conclude that the CAM may facilitate activation by changing confor-
mation of W2936.48.
The upper half of TM3 (near the mutation site) and the lower half of TM7 are more flexible in the CAM than 
the WT (Fig. S11a). This emerged from a “core”-residue analysis (see “Methods”). An intramolecular community 
network analysis (see “Methods”) shows that these two regions in the CAM are less coupled to the neighboring 
regions than those in the WT (Fig. S11b). These may contribute to facilitating the transition of the CAM from IS 
to AS-L, as also suggested by Krumm et al. about the NTS1 CAM17.
INT shows similar conformation at the orthosteric pocket to that in Xtl-AS despite the absence of ligand. In 
particular, residue Y1282.64, conserved across opioid receptors, has been suggested to play a role in ligand binding 
and μ OR conformational changes37. In CAM INT, this residue inserts between TM1 and TM7, and the orthosteric 
pocket resembles that in Xtl-AS. Being confident about the predicting power of our calculations (that reproduce 
the known structural features and traits of activation), here we suggest that INT might represent a very early 
intermediate state that escaped so far experimental characterization. Such intermediate state is possibly highly 
unstable in WT and thus difficult to capture experimentally. This could be a reason why this state is not seen nei-
ther in X-ray nor in NMR structures of apo GPCRs.
Can these results provide insights into agonist-induced activation in the receptor? We suggest that such 
interpretation should be made with caution. There exists evidence that constitutively active WT μ OR activates 
individual G-proteins differently than an agonist15, and agonist-induced conformational changes in the neuroten-
sin receptor 1 differ from those in a CAM17. Here we have demonstrated the power of the enhanced sampling 
approach– the so called REST2. This approach can be readily applied to study agonist-induced activation. Work 
is in progress in our lab to address this fascinating issue.
The N1503.35A mutation in apo μ OR diminishes Na+ binding at the allosteric site and the inhibitory effect 
of the ion on activation. The mutation impacts on the neighboring toggle switch conformation, particularly on 
W2936.48. This in turn may trigger activation independent of agonist, as suggested for the NTS1 CAM17. The over-
all receptor structure is more flexible with less intramolecular coupling than in the WT. The mutation also induces 
a novel state with Xtl-AS-like features at the orthosteric site, which may represent an intermediate state that favors 
agonist binding. This state may also reduce the energy barrier of activation, thus facilitating this process.
Methods
The initial models of μ OR WT and CAM were both based on the inactive X-ray crystal structure of μ OR (PDB 
code: 4DKL)28. The WT model was built using the procedure described in our previous work (see SI-Method)38. 
The N1503.35A mutation was introduced using the Swiss PDB Viewer39. Hydrophilic cavities in the models were 
detected and pre-filled with water using the DOWSER program40. The g_membed tool41 was used to embed 
each protein model in a bilayer of 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), the most abun-
dant phospholipid in animal cell membranes42. The system was then solvated in a periodic 67 × 70 × 107 Å3 box 
of explicit water and neutralized with 0.15 M NaCl. Finally, the simulation system consisted of ~49,000 atoms, 
including ~9,450 water molecules, 28 Na+ and 41 Cl− ions.
The “Stockholm Lipids”43, Amber99SB-ildn44, TIP3P45 and the Joung-Cheatham46 force fields were used for the 
lipids, the protein, the water molecules and the ions, respectively. The simulation system was energy minimized and 
CAM WT
Allosteric Na+ ion lifetime 2% 18%
W2936.48 sidechain orientation (χ 2 dihedral angle) IS: − 74.3 ± 11.4 73.2 ± 16.2
I1553.40 sidechain orientation (χ 1 dihedral angle) IS: − 60.4 ± 5.8 − 59.9 ± 8.0
P2445.50-F2896.44 minimal sidechain distance IS: 5.8 ± 0.9 6.5 ± 0.4
Number of “core” residues (see “Methods”) 50 65
Intramolecular community network CAM shows weaker coupling around the mutation site, in the upper half of TM3 and the lower half of TM7 than the WT
Table 1.  Selected differences between the CAM and the WT (mean ± standard deviation are given when 
applicable).
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gradually heated to 300 K. REST2 simulations were then performed in the NPT-ensemble (P = 1 bar, T = 300 K) 
with 64 replicas, applying the Andersen-Parrinello-Rahman barostat47,48 and the Nose-Hoover thermostat49. The 
effective temperature ranged from 300 K to 550 K, following a distribution calculated with the Patriksson-van der 
Spoel approach50. This choice led to an exchange probability ranging from 34% to 63% (~55% on average). All the 
simulations were carried out with Gromacs 4.651. The CAM and the WT each underwent 20 ns × 64 replicas of MD 
simulations. Discarding the first 2 ns, trajectories at 300 K were analyzed. Residues experiencing the least fluctua-
tions (the “core” residues) were identified using the Bio3d program and 1 Å3 volume cutoff52. Intramolecular com-
munity network analysis was performed using the NetworkView plugin for VMD53. PCA was employed to identify 
and characterize clusters of structures, just as is usually done in protein folding dynamics54. These were carried out 
with Gromacs tools51. More details of the simulation and analyses can be found in SI-Methods.
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